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Whilst Cognitive Behavioural Therapy (CBT) is the treatment of choice for obsessive-compulsive 
disorder (OCD), around half of the participants do not experience remission following treatment. As 
yet, there is no comprehensive systematic review of the extent to which patient non-adherence 
presents a challenge to the overall benefit of CBT for OCD. The aim of this systematic review and 
meta-analysis was to identify the magnitude, moderators and reasons for poor patient adherence to 
CBT for OCD in terms of: (1) treatment refusal; (2) treatment dropout; (3) session attendance/module 
completion, and (4) between-session CBT task adherence. Sociodemographic and clinical variables, 
treatment and study design characteristics were examined as moderators of adherence. The systematic 
search identified 123 studies including 5627 participants taking part in CBT or control conditions. A 
pooled rate of 15.6% of eligible patients refused CBT and a further 15.9% of treatment starters 
dropped out from treatment. Group CBT had significantly lower dropout rates than individually-
delivered CBT. No other significant moderators were found. Most studies reported moderate to good 
adherence to between-session CBT tasks, which had a significant medium to large association with 
post-treatment OCD symptom reduction. Recommendations for enhanced measurement and reporting 
of patient adherence to CBT for OCD are made along with clinical implications of findings. 
 


















1.1. Background  
Obsessive compulsive disorder (OCD) is a mental health condition characterised by persistent 
intrusive thoughts, images or urges that cause significant anxiety (obsessions), and repetitive, 
ritualistic behaviours or mental acts aimed at neutralising anxiety or preventing a dreaded event 
(compulsions) (American Psychiatric Association (APA), 2013). It has a high current and lifetime 
comorbidity with depression and anxiety and is associated with poor quality of life (Macy et al., 
2013).   
UK and US practice guidelines recommend exposure and response prevention (ERP), 
delivered with or without cognitive therapy strategies, as the psychological therapy of choice for OCD 
(APA, 2007; National Institute for Health and Care Excellence (NICE), 2005). Exposure and response 
prevention is a behaviour therapy during which patients engage in repeated, prolonged exposure to 
obsessions whilst refraining from compulsions (Kozak & Foa, 1997). Cognitive strategies, rooted in 
the cognitive therapy (CT) model of OCD, help patients re-evaluate the accuracy of appraisals (i.e. 
exaggerated beliefs about personal responsibility for preventing harm) that result in the 
misinterpretation of common intrusive thoughts as significant and therefore anxiety-provoking 
(OCCWG, 1997; 2005). In this review, CBT is the umbrella term for ERP, CT and a combination of 
both.a 
 Öst and colleagues (2015) conducted a large meta-analysis of the efficacy of CBT for OCD. 
They report a large post-intervention between-group effect size for CBT compared to waitlist 
(Hedges’ g= 1.31, CI [1.08,1.55], k=15) and placebo (g=1.33, 95% CI [.91-1.76], k=8) conditions and 
a medium effect size compared to antidepressant medication (g=.55, 95% CI [.05, 1.04], k=4), using 
                                               
a In the meta-analysis, CBT also denotes the combination of ERP and cognitive therapy strategies, contrasted 










the Yale–Brown Obsessive Compulsive Scale (Y-BOCS) (Goodman et al., 1989) as the outcome 
measure.  
Whilst CBT is the gold standard in the treatment of OCD, not all patients achieve post-treatment OCD 
symptom remission. A patient is in remission when they no longer meet diagnostic criteria for OCD 
and have minimal to no symptoms and no functional impairment, lasting for at least one week 
(Mataix-Cols et al. 2016). Research trials of CBT for OCD typically determine remission based on 
whether the patient moved from above to below a nominated YBOCS cut-off score from pre- to post-
treatment (Mataix-Cols et al., 2016). However, attempts to establish a reliable remission rate 
have been marred by the variability in nominated Y-BOCS cut-off scores (Mataix-Cols et al., 
2016). For example, Öst et al. (2015) found that just 42 to 52% of patients experienced remission 
following CT, ERP or CBT. Eighteen of the 20 primary studies contributing to these pooled estimates 
determined remission based on a YBOCS cut-off score. In the absence of normative data for the 
YBOCS, studies used cut-off scores derived from sample-dependent calculations (e.g. pre-treatment 
sample mean - 2SDs) (Jacobson & Truax, 1991), or from empirical studies (e.g. Fisher & Wells, 
2005; Lewin et al., 2011) or followed recommendations from OCD experts (e.g. Pallanti et al., 
2002). Consequently, Y-BOCS cut-off scores ranged from 7 to 16 across studies. Some international 
OCD experts recently suggested that a YBOCS score of ≤ 12 should be used (Maitaix- Cols, 2016). 
However, other experts have made a distinction between wellness and recovery and have underlined 
that recovery from illness in OCD, as is the case for other disorders, should be defined as no longer 
meeting criteria for illness, that is YBOCS ≤ 7, with consistency among interview and psychometric 
indices (e.g. Pallanti & Quercioli, 2006; Sookman & Steketee, 2010). Therefore, several of the 
primary studies in Öst et al. (2015) used Y-BOCS scores that were either too lenient or too 
stringent. Despite these methodological limitations, these figures suggest that a significant proportion 










CBT for OCD is often seen as a challenging therapy; it is anxiety provoking by design and 
this is magnified by high levels of distress intolerance associated with OCD (Cougle, Timpano, Fitch, 
& Hawkins, 2011; Olatunji, Deacon, & Abramowitz, 2009). It is often suggested this may result in 
poor patient adherence to treatment and account for the moderate remission rates for CBT for OCD 
(e.g. Whittal, Thordarson & McClean, 2005).  However, little is known about the magnitude and 
moderators of patient adherence to CBT for OCD and the extent to which non-adherence may be 
attributable to patients finding the therapy challenging. This is an important evidence gap to address – 
understanding these factors could lead to therapy modifications to improve adherence and ultimately 
to improve patient outcomes. This is the focus of the present study. 
The World Health Organisation defines adherence as ‘the extent to which a person’s 
behaviour… corresponds with agreed recommendations from a health care provider’ (Sabate, 2003, 
p.3). In this study, we consider four adherence factors that could contribute to disappointing 
outcomes: (1) therapy refusal, i.e. choosing to decline treatment despite professional recommendation; 
(2) therapy dropout, i.e. the patient prematurely discontinues therapy recommended by their health 
care provider and is unlikely to have received the full benefit of treatment; (3) poor attendance at 
therapy sessions despite treatment completion, which can result in people not receiving the therapist 
recommended ‘dose’ of the therapy; and (4) poor adherence to therapist recommended between-
session ERP/behavioural tasks considered key in achieving symptom improvement.  
1.2. Refusal 
  Research to date has not yet established a reliable estimate of the refusal rate for CBT for 
OCD. Öst et al. (2015) report an average 15% rate of refusal, pre- and post-randomisation, across 32 
RCTs of CBT for OCD. Refusal rates were highly variable across studies (SD: 11.6, range: 0-63%). 
Assessing the magnitude of CBT refusal in the context of RCTs can be problematic as it may reflect 
refusal unrelated to CBT, e.g. refusal to be randomised. To gain a reliable estimate of the magnitude 











1.3. Dropout  
Dropout occurs when the patient accepts the offer of CBT and attends at least one session but 
does not complete the full recommended course of treatment. There are a few meta-analyses of the 
magnitude of dropout from CBT for OCD, with a modest number of studies. Öst et al. (2015) report a 
pooled dropout rate for (remote and face-to-face) CBT ranging from 11% (CT, k=8) to 19% (ERP, 
k=28). Swift & Greenberg (2014) found a CBT (all types) dropout rate of 16.3% across a combination 
of controlled and uncontrolled studies (k=45), whilst Hans and Hiller (2013) report a dropout rate of 
12% for face-to-face CBT for OCD across 20 nonrandomised effectiveness studies.  
1.4. Session Attendance 
US practice guidelines (APA, 2007) recommend a minimum of 13 sessions of CBT whilst 
UK guidelines (NICE, 2005) propose high intensity CBT (> 10 therapist hours per patient, i.e. 
individual CBT) for those patients with moderate to severe OCD or those with mild OCD who failed 
to engage with or benefit from low intensity CBT (<10 therapist hours per patient, i.e. guided self-
help, group CBT). It is therefore important to consider whether among patients completing therapy, 
session attendance or module completion (for remote therapies) was optimal. However, this aspect of 
adherence is infrequently considered (Tetley, Jinks, Huband, & Howells, 2011). 
1.5. Between-Session Tasks 
Cognitive behavioural therapy places central importance on the regular completion of 
between-session therapy tasks. A recent meta-analysis found significant large effect sizes for the 
association of quality (Hedges’ g=.78, 95% CI [.03, 1.53], k=3, n=417, I²=91) and quantity (g=.79, 
95% CI [.57, 1.02], 1.53], k=15, n=1537, I²=81) of homework compliance with post-treatment 
outcomes for CBT  for a range of mental health conditions and physical health issues (Kazantzis et al., 
2016). However, results were not specific to key homework tasks of CBT for OCD. 
 










An examination of  moderators of adherence  to CBT for OCD is key in the identification of 
risk factors for nonadherence, to drive a targeted approach to keeping patients engaged with therapy 
(Barrett, Chua, Crits-Christoph, Gibbons, & Thompson, 2008).  To date, there are no meta-analyses 
that consider moderators of refusal, session/module completion and therapy task adherence, but a few 
studies have tested moderators of dropout from CBT for OCD. Öst et al. (2015) examined CBT type 
and found that dropout from ERP + antidepressant medication (32%, k=7) was significantly higher 
than from CT, ERP or CBT (15.5%, k=19), suggesting that the elevated dropout rate might be due to 
the addition of medication (dropout from antidepressant medication alone was 30%). Ong, Clyde, 
Bluett, Levin, & Twohig (2016) found that treatment type and format did not moderate dropout from 
ERP. Therapist experience (coded as: i) no professional experience, ii) professional experience not 
specific to CBT and, iii) professional experience with or expertise in CBT) and qualification (coded 
as: i) student, ii) non-psychologist professional or therapist, or iii) doctoral level therapist or 
psychologist) and number of sessions also did not predict dropout. These meta-analyses examined a 
small number of moderators and some were conducted with a relatively small (sub)group of studies 
and could have been under-powered to detect moderator effects (Borenstein et al., 2009).  
To understand what might help patients to engage with therapy, it is important to consider the 
reasons participants give for not adhering to therapy. However, few studies have foregrounded this. 
An observational study found that environmental barriers (e.g. costs, inconvenience) was the main 
reason for refusing (55%) and dropping out (46%) from CBT for OCD (Mancebo, Eisen, Sibrava, 
Dyck, & Rasmussen, 2011). Interestingly, 20 % of refusal and 12% of dropout was primarily due to 
feeling too anxious or fearful to participate in CBT. This suggests that (patient perceptions of) the 
challenging nature of CBT for OCD may contribute to nonadherence. Further studies are needed to 
establish if this is a consistent finding. 
1.7. Objectives for a systematic review and meta-analysis 
Developing a better understanding of the magnitude and moderators of adherence to CBT to 










systematic review and meta-analysis with a primary focus on patient adherence to CBT for OCD. The 
aim was to examine the magnitude of refusal and dropout, session attendance, step/module 
completion and between-session task adherence and to summarise participants’ reasons for refusing or 
dropping out from CBT across studies. In line with models of health service utilisation (Andersen, 
2017; Barrett et al., 2008; Owens et al., 2002), a range of sociodemographic, clinical, treatment 
characteristics were tested as potential moderators of patient adherence to CBT. Study characteristics 
were also examined as they may influence adherence (e.g. Fernandez et al. 2015; Swift & Greenberg, 
2012). The aim was also to examine the strength of the association of session attendance and therapy 
task adherence with post-treatment OCD symptom reduction, to further our understanding of the 
importance of these aspects of adherence to therapy outcomes. Findings will help inform 




2.1. Literature search 
PsycINFO, PsycArticles, Medline, Web of Science and SCOPUS were searched from their 
inception until 31st October, 2017, using the search terms: (OCD OR “Obsessive compulsive 
disorder" OR obsess*) AND (cognitive therapy OR behavio?r* therapy OR exposure* OR CBT). 
OCD terms were searched in the title and CBT terms were searched in the title, abstract or 
keyword/subject.  
Results from electronic searches were checked against systematic reviews of CBT for OCD 
(Mataix-Cols & Marks, 2006; Öst et al., 2015; McKay et al. 2015; Olatunji, Davis, Power & Smits, 
2013; Ponniah, Magiati & Holland, 2013; Rosa-Alcazar, Sanchez-Meaca, Gomez-Conesa & Marin-
Martinez, 2008). International clinical trial registries (ClinicalTrials.gov, ISRCTN, EU clinical trials 
register) were searched using the terms OCD and obsessive-compulsive disorder. Finally, the 











2.2. Selection criteria 
Studies were included if: 1) they evaluated CBT for OCD using any design, except single 
case; 2) they were published in English; 3) they recruited a working age adult sample (majority of 
participants aged 18+); 4) with participants who met diagnostic criteria for OCD, based on DSM/ICD 
or equivalent criteria; 5) intervention participants received CBT for OCD in an outpatient setting; 6) 
quantitative or qualitative data on (reasons for) CBT treatment refusal, treatment drop-out and/or 
degree or quality of client adherence to therapy sessions and/or therapy tasks was provided.  
In this meta-analysis, CBT type is defined as ERP, CT or a combination of (components of) 
the two (CBT). Face-to-face and remote therapies were included as were therapies delivered in 
combination with psychotropic medication or (psychological) placebo.  
Studies were excluded if they: 1) included participants who met diagnostic criteria for 
psychosis, autistic spectrum disorder or a learning disability; 2) were single case studies; 3) lacked 
details of the CBT provided, e.g. no information about duration or content ; 4) recruited inpatients, as 
inpatient treatment refusal may reflect refusal of a hospital stay more generally; and 5) if identical 
adherence data from the same study were reported in multiple papers only the first published paper 
was selected for review. 
 
2.3. Data extraction & coding 
The following information was extracted and coded for each study: authors, year of 
publication, design, treatment type (ERP, CT or CBT with or without medication and/or 
(psychological) placebo), treatment format (i.e. (therapist assisted or self-help) remote therapies 
versus face-to-face (individual, family, couple or group) therapies), protocol treatment duration in 
weeks, number and hours of sessions, weekly frequency of treatment sessions, therapist experience, 
sample characteristics (age, % female, % married or co-habiting, % working full-time or part-time, 










sample with prior (adequate) CBT, % on medication at the start of therapy, % comorbidity), refusal 
data (number of eligible participants, number of eligible participants refusing participation, reasons 
for refusal), dropout data (number of participants starting and dropping out from treatment, stage of 
dropout, reasons for dropout), session and task adherence data (percentage or average number of 
sessions attended, percentage or average number of (hours of) between-session CBT tasks completed; 
(source, type and timing of) measures of therapy task adherence; the association between task 
adherence and therapy outcome; predictors of adherence). In addition, this review coded the clinical 
representativeness of the study sample. Based on guidelines set out in Hans & Hiller (2013), the 
following criteria were applied: 1) routine referrals (vs some active recruitment, e.g. through 
advertising); 2) allowance of medication; 3) common exclusion criteria for routine outpatient 
treatment (vs additional exclusion criteria). A score of 1 meant the criterion for clinical 
representativeness was met (see appendix A for the scale).  
 
2.4. Categorisation of variables 
The following sets out how the different adherence variables examined in this review were 
categorised.  
 
2.4.1. CBT refusal 
Any patient who was eligible to commence CBT but declined participation for any reason 
counted as a refusal. Assessing refusal in RCTs is challenging because pre-randomisation refusal 
could reflect refusal of conditions other than CBT (e.g. medication, wait-list) or of randomisation, 
whereas post-randomisation refusal of CBT underestimates refusal rate as it excludes patients who 
refused pre-randomisation based on the possibility of receiving CBT. Therefore, only refusal data 
from uncontrolled studies was used to calculate the CBT treatment refusal rate as it was clear which 











2.4.2. CBT dropout 
A patient was counted as a treatment dropout if they attended at least 1 treatment session but 
discontinued treatment before the final planned session. Patients who completed treatment but did not 
attend a post-treatment assessment were not counted as CBT dropouts. For studies comparing more 
than one treatment, separate dropout rates were recorded for each treatment. The reasons for CBT 
treatment dropout were not taken into consideration, to ensure equivalence between studies that did 
and did not report this information. Reasons for dropout were analysed separately (below). 
 
2.4.3. CBT session attendance or step/module completion 
The mean number and percentage of attended sessions, as a proportion of the total number of 
planned sessions, were recorded.  For remote therapies, the number and percentage of completed 
modules or steps completed were recorded.  
 
2.4.4. CBT task adherence 
The mean degree of adherence to between-session CBT tasks, e.g. mean number or 
percentage of tasks completed or the mean score on a CBT task adherence questionnaire, was 
extracted. Where available, ratings of the quality of task adherence were also recorded.  
 
2.5. Statistical analyses 
All data analyses were conducted using Comprehensive Meta-Analysis version 3 (Borenstein 
et al., 2009).  
 
2.5.1. Mean adherence 
Where possible, the following inverse variance weighted effect sizes were calculated and 
pooled using random effects models, as the true effect size was expected to vary between studies 










proportions (Borenstein et al., 2009; Lipsey & Wilson, 2001). Dropout rates were calculated at the 
treatment level. To ease interpretation, logit-transformed proportions and 95% confidence-intervals 
were back-transformed into proportions; ii) Mean number and percentage of completed CBT sessions 
or modules, calculated at treatment level; iii) Mean number, percentage and/or mean score for 
between-session CBT task adherence, calculated at treatment level; iv) Risk ratio of early (session 1-
5) versus late (sessions 6 and after) dropout, calculated at treatment level. The sensitivity of the 
pooled effect sizes to the impact of individual studies was examined by removing one study at a time 
and obtaining the re-calculated mean rate, number or percentage (Borenstein et al., 2009).  
 
2.5.2. Moderator/subgroup analysis  
The following categorical study and therapy characteristics were tested as potential 
moderators of adherence: 1) study design (controlled versus uncontrolled); 2) type of CBT (ERP, CT, 
CBT with/without medication or pill/psychological placebo); 3) therapy format (i.e. face-to-face 
versus remote therapies; individual versus group, couple or family therapies; therapist-assisted versus 
self-help remote therapies) 4) intensity (face-to-face and remote therapies involving 10 hours or less 
of sessions or modules are considered ‘low intensity’ whereas those of more than 10 sessions or 
modules are considered high intensity (from the patient perspective); 5) face-to-face session 
frequency (more than twice weekly; twice weekly; once weekly or less); 6) face-to-face therapy 
duration (in weeks); 7) therapist experience for therapist delivered treatment (pre-attainment, post-
attainment, mixed); 8) recruitment (routine vs active (e.g. using advertising)); 9) patients (routine vs 
non-routine exclusion criteria); 10) medication (allowed, not allowed).  
 Subgroup effect sizes were calculated if there were at least 4 studies per subgroup (Fu et al., 
2011). A mixed-effect model was used to compare differences between subgroup effect sizes as effect 
sizes of studies within each subgroup were expected to vary (Borenstein et al., 2009). Differences 










or t-tests for testing group differences in primary studies (Borenstein et al., 2009), i.e. it determines if 
differences in effect size between subgroups are statistically significant.  
Moderator analyses of the following continuous socio-demographic and clinical variables 
were carried out where possible, using a mixed-effects model of meta-regression (Method of 
Moments) (Borenstein et al. 2009; Kelley & Kelley, 2012): 1) mean age; 2) gender (% female); 3) 
ethnicity (% Caucasian); 4) marital status (% married or cohabitating); 5) employment status (% 
working full- or part-time); 6) mean years of education; 7) pre-treatment mean OCD symptom 
severity (Y-BOCS); 8) % patients with comorbid axis I or II disorders; 9) pre-treatment depression 
and/or anxiety symptom severity; 10) % patients with prior CBT, and 11) % patients on concurrent 
medication. Only covariates for which at least 10 studies (k) provided data were included (Borenstein 
et al., 2009).  
 
2.5.3. Association of CBT task adherence with post-treatment OCD symptom reduction.  
The association between task adherence and post-treatment OCD symptom reduction was 
tested by meta-analysing Fisher’s z-transformed correlations of mean between-session CBT task 
adherence with post-treatment OCD symptom reduction. Where correlations were not reported, the 
available statistics were converted into correlations using standard formulas (Borenstein et al., 2009). 
Where possible, correlations based on post-treatment OCD symptom severity adjusted for pre-
treatment OCD symptom severity were selected; otherwise correlations with change scores or post-
treatment scores were used. The type of correlation and outcome measure needed to be equivalent 
across studies to pool effect sizes (Aloe & Thompson, 2013). 
 
2.5.4. Homogeneity analysis 
The Q-statistic (Hedges & Olkin, 1985) was calculated to test for statistically significant 










to assess the degree of heterogeneity using the following guidelines: 25% (small), 50% (moderate), 
75% (large) heterogeneity (Higgins, Thompson, Deeks & Altman, 2003). 
 
2.5.5. Publication bias 
Risk of publication bias was analysed using Egger’s regression intercept (Egger, Davey 
Smith, Schneider, & Minder, 1997) and Duval and Tweedie (2000) trim-and-fill methods (Borenstein 
et al., 2009).  
 
2.6 Reasons for dropout or refusal 
Reasons for refusal or dropout were recorded as stated by study authors, along with the 
number of participants that the reason applied to. The frequencies for identical reasons (that differed 
minimally in their wording), were totalled across studies and grouped into different low-level 




3.1. Study flow and characteristics 
The database and hand searches identified 7725 references. After the removal of 3527 
duplicates, 4198 references remained. After excluding 3812 references based on their title, abstract or 
source, 386 full-text articles were read to assess their eligibility. This resulted in the inclusion of 123 
studies (see Fig. 1). Six studies that conducted further analyses with adherence data drawn from 
outcome studies already included in the meta-analysis were not included in the study characteristics 
below. The 117 remaining studies included 59 controlled and 58 uncontrolled studies, published 
between 1984 and 2017. A total of 5627 participants took part in CBT or control conditions. 
Averaging the unweighted sample means, the mean age was 34.9 (range: 25.71 - 47.93) and 58% of 










30.38 with a mean of 24.49 (severe symptoms). Mean pre-treatment depression symptom severity 
(measured with the Beck Depression Inventory (BDI) (Beck, Steer & Garbin, 1988) was 17.58 (mild 
depression) (range: 10.40-28.50). Mean duration of OCD symptoms was 14.10 years (range: 4.6 - 
26.40) and 53% of participants were on medication (range: 13 - 100%). The studies delivered 161 
CBT treatments in total, including ERP (68), CBT (55), CT (16), ERP + medication (12), ERP + 
Placebo pill (6), CBT + medication (2), CT + medication (1), and ERP + Psychological Placebo (1). 
Treatments were delivered face-to-face (k=125) and remotely (k=36). See Appendix B for study 
references, Table C.1., Appendix C for details of primary studies included under each 
adherence variable and Table C.2 and C.3, Appendix C for study characteristics. 
 
3.2. Mean adherence  
Twenty-six uncontrolled studies contributed to the refusal rate. CBT treatments included 
CBT (13), ERP (12) and ERP + Medication (1).  The pooled mean dropout rate was calculated with 
data from 111 studies (controlled studies: 55, uncontrolled studies: 56) that included 153 treatments: 
ERP (62), CBT (53), CT (16), ERP + Meds (12), ERP + Pill Placebo (6), CBT + Meds (2), CT + 
Meds (1), ERP + Psych Pla (1). The mean number of sessions attended by patients completing face-
to-face CBT could be extracted from only 8 studies, whilst the mean percentage sessions attended 
was calculated with data from 7 studies. Treatments included ERP (7), CBT (2) and CT (1) using 
group (2) and individual (8) formats. Eight studies reported the average number of steps or modules 
completed in remote therapies. Eight out of 10 treatments involved CBT (i.e. ERP and cognitive 
strategies combined). All were internet-based apart from one bibliotherapy treatment. Seven of the 10 
treatments involved (a degree of) therapist assistance. See Appendix B for details of primary studies 
included under each adherence variable. 
The pooled CBT refusal rate was 15.6% (95% CI [11.9, 20], k=26, I² =52.36, Q = 52.47, p 
<.001) and pooled dropout rate was 15.9% (95% CI [14.2, 17.8], k=153, I² =50.8, Q =308.95, p 










[12.03, 13.56], k=10, I² =95.79, Q =213.64, p<.001) or 87.32% of all scheduled sessions (95% CI 
[82.63, 92.09], k=9, I² =95.4, Q =174.03, p<.001). Participants accessing remote therapies completed 
a mean of 5.69 steps/modules (95% CI [4.28, 7.1], k=10, I² =98.76, Q =724.35, p <.001) or 75.7% of 
all scheduled steps/modules (95% CI [60.61, 91.12], k=10, I² =97.73, Q =397.13, p <.001). Due to the 
use of varied measures of between-session CBT task adherence and a mix of ITT and completer 
samples, it was not possible to meta-analyse mean CBT task adherence scores (see descriptive 
summary below). 
There was moderate heterogeneity of study refusal and dropout rates. Sensitivity analyses 
showed that the pooled rate of refusal (range: 14.7 - 16.5%) and dropout (range: 15.6 - 16.1%) was 
stable when removing one study per pass. The study estimates for session attendance and module 
completion were highly heterogeneous, which suggests session attendance and step/module 
completion were influenced by moderator effects.  The mean number (range: 12.7 - 13.6) and 
percentage of sessions attended (range: 86.7% - 89.1%.) was stable across studies. For remote 
therapies, the mean number (range: 4.6 - 6.9) and percentage (range: 66.4% - 92.4%) of completed 
steps/modules was less stable.   
 
3.3. Mean between-session CBT task adherence  
Table 1 provides an overview of the 14 studies (k=20) that reported mean between-session 
CBT task adherence. Treatments included therapist-delivered (face-to-face) ERP (9), CBT (1) ERP + 
meds (2), ERP + Placebo (2; pill=1, psychological = 1) and CT (2), and remotely delivered ERP (3; 
self-help (1), therapist-assisted (2)) and CBT (1, self-help). Thirteen out of 14 studies rated adherence 
to between-session ERP tasks and one study rated adherence to CT appraisal change exercises such as 
behavioural experiments and surveys (Whittal, Woody, McLean, Rachman & Robichaud, 2010). Two 
studies also rated the extent to which participants read ERP self-help materials (Tolin et al., 2007; 
Tolin, Diefenbach & Gilliam, 2011). Rowa et al. (2007) and Tolin et al. (2011) reported a combined 










final therapy session (Abramowitz et al., 2002; Fals-Stewart et al., 1993; Seol et al., 2016; Tolin et al., 
2004; Tolin et al., 2007). The remaining nine studies rated task adherence at each session.   
Three therapist-rated measures were used in more than one study: i) Patient Exposure 
Adherence Scale (PEAS) (Simpson, Maher, et al., 2010); ii) Homework Compliance Scale (HCS) 
(Primakoff, Epstein & Covi, 1986; Leung & Heimberg, 1996), and iii) Clinician Rated Effort Scale 
(CRES) (Tolin, Maltby, Diefenbach, Hannan & Worhunsky, 2004). The PEAS calculates a total score 
based on an aggregate of participant scores on a 7-point Likert scale for: a) quantity of exposure, b) 
quality of exposure, and c) degree of ritual prevention. Scores are aggregated across these items for 
each session, then averaged across all sessions. The PEAS has good content validity and excellent 
inter-rater reliability (ICC ≥.97) (Simpson, Maher et al., 2010).  The HCS rates the extent to which 
participants attempted to complete their assigned ERP tasks on a 6-point Likert scale. It has no 
reported evidence for its psychometric properties. The CRES is a 5-point Likert scale rating the 
degree of effort participants put into assigned ERP tasks and, for bibliotherapy, the proportion of 
assigned reading completed (Tolin et al., 2007, 2011). Tolin et al. (2004) demonstrated good inter-
rater reliability for the CRES (r=.82) but other psychometric properties are unknown. Tolin et al. 
(2011) elaborated on the CRES with the Homework Compliance Rating Form (HCRF), using 6-
point Likert scales to score i) the amount of effort participants put into ERP, ii) the time spent on 
exposure and, iii) the amount of assigned reading completed (bibliotherapy). Both patients and 
therapist scored the HCRF. See Table D.1 in Appendix D for an overview of anchor points for 
these scales. 
Other measures of adherence included: iv) a therapist-rated 7-point Likert scale of compliance 
(0 (poor) to 6 (outstanding)) with homework exposure instruction and self-monitoring of rituals 
(refraining from rituals/accuracy of recording rituals) (Abramowitz, Franklin, Zoellner, & 
DiBernardo, 2002), v) the number of ERP assignments completed (Vogel, Stiles & Gotestam, 2004) 










homework tasks completed (or effort made) (0-100%) (Cottraux et al., 1990; Rowa et al., 2007); vii) 
patient-rated extent of participation in remote CBT (0-100%) (Seol, Kwon, Kim, Kim & Sin, 2016). 
For  therapist-delivered treatments (13 studies including 17 treatments (face-to-face =16 , 
videoconference = 1) , the results from 5 studies suggest good/above average mean adherence to 
between-session ERP tasks, based on study authors’ interpretation of mean adherence ratings as 
‘good’ (75-90 % good quality task completion with some to minimal compulsions) or ‘high’ (77-82.5 
% task completion) (Cottraux et al.,1990; Goetter et al. 2013; Rowa et al., 2007; Simpson, Zuckoff,  
et al., 2010; 2013). Three further studies report moderate/average mean adherence, as mean ratings 
showed patients were ‘moderately compliant’ and put in ‘between some to much’ and ‘between some 
to average’ effort, respectively (Abramowitz et al., 2002; Tolin et al., 2007, 2011). One study reported 
poor/below average mean adherence as authors describe patients as putting in ‘minimal to some’ 
effort (Tolin et al., 2004). The latter study attributed the relatively poor adherence to their treatment 
refractory sample of participants with severe OCD, high rates of comorbidity and relatively poor 
insight. The results from 4 further studies were not entirely clear. Fals-Stewart & Lucente (1993) did 
not stipulate the number of assigned homework tasks so it was not possible to calculate the proportion 
of completed assigned tasks. However, the authors report that participants, who on average missed 3 
assigned homework tasks, were compliant. Vogel et al. (2004) also do not report the exact number of 
assigned tasks but results suggest that mean adherence was at least adequate as on average 
participants engaged in a total of 17-20 weekly tasks ERP tasks over a 9-week period. Results from 
studies involving the HCS were also more ambiguous (Whittal et al., 2005; Whittal et al., 2010) as the 
mean CBT task adherence score represented participants doing ‘a portion’ of the assigned homework 
tasks (scale-point 4), without specifying the size of the portion or the quality of exposure (Primakoff 
et al., 1986). Whittal et al. (2010) did specify that participants did ‘most of their assigned tasks each 
week’ (p. 298), which suggests a good degree of adherence. For self-administered ERP, mean 










(Tolin et al., 2007) to moderate adherence for ERP with at least some therapist assistance (Seol et al., 
2016; Tolin et al., 2011). 
 
3.4. Stage of dropout 
Twenty-four studies reported the stage of dropout, coded as early (after sessions 1-5) or late 
(after session 6). Across studies, 690 participants started CBT treatment and 130 dropped out. 
Treatments included ERP (12), CBT (11), CT (3) and ERP + meds (2). The pooled risk ratio (RR) 
was 2.45 (95% CI [1.38, 4.35], k=28, z=3.044, p=.002; I² = 31.39, Q (27) = 39.35, p =.06) towards 
early dropout (see Appendix E for the forest plot).  
 
3.5. Moderators of adherence  
There were no significant categorical moderators of refusal; treatment and study design 
characteristics did not predict refusal (see Table F.1 in Appendix F). As studies did not include 
patients refusing participation in their reported sociodemographic and clinical sample characteristics, 
it was not possible to conduct a meta-regression with these variables. 
There was just one significant moderator effect for dropout (see Table F.2 in Appendix F). 
The dropout rate for group therapy (12.9%, 95% CI [10.0, 16.6], k=23, I² = 18.36, Q=28.17, p=.17) 
was significantly lower (Q=4.28, p =.039) than for individual face-to-face therapy (17.3%, 95% CI 
[15.4, 19.4, k=99, I² = 38.36, Q=158.99, p <.001). Meta-regression showed that none of the pre-
determined socio-demographic (age, gender, ethnicity, educational attainment, employment and 
marital status) or clinical variables (OCD, depression and anxiety symptom severity, OCD duration, 
rates of Axis 1 comorbidity, major depression, medication and prior CBT) of treatment starters were 










There were too few cases (in each subgroup) to conduct moderator analyses of mean number 
and % session attendance and/or module completion (Borenstein et al., 2009). As mean CBT task 
adherence could not be meta-analysed it was also not possible to test moderator effects.  
 
3.6. Reasons for non-adherence 
Reasons for refusal were reported by just 8 of the 26 uncontrolled studies for which refusal 
rates were established. Reasons for refusal were given for a total of 29 participants. Treatment 
conditions included ERP (3), CBT (4), ERP + medication (1). Therapies were delivered individually 
(2), in a group (3), couple (1) and remotely with therapist assistance (2).  
Forty-one (controlled: 24, uncontrolled: 17) of the 111 primary studies contributing to the 
pooled dropout rate provided reasons for 211 dropouts. A total of 50 treatments included CBT (21), 
followed by ERP (13), ERP + medication (6), CT (5), CBT + medication (2), ERP + Placebo (2) and 
CT + medication (1). Studies involved therapist-delivered individual (27), group (12), family (1), 
couple (1) and a combination of group and individual (1) therapy. Remote, internet-based therapist-
assisted (7) and self-help (1) therapies were also included.  
For each included study, reported reasons for refusal or dropout were recorded together with 
the number of participants the reason applied to. The frequencies for semantically identical reasons 
were totalled across studies and grouped into different low-level categories, e.g. ‘preferred to wait for 
individual therapy’ and ‘did not want group therapy’ were grouped together under ‘did not want group 
treatment (preferred individual therapy)’. These low-level categories were grouped together under 
higher-level categories, e.g. refusal due to ‘treatment type and format’. 
 Table 2 reports the total number and proportion of participants (out of 29) to which each 
refusal reason and category applied. Results show that within this small group of 8 studies, not having 
one’s treatment preferences met was the most common reason for refusal (79%), particularly 










Table 3 provides an overview of the reasons for dropout. The most common reason was low 
motivation or a lack of engagement (28%). For 14% of the participants, feeling too anxious about 
ERP or a reluctance to engage with (further) ERP was specifically listed as the reason for dropout. 
The second most common reason for dropout was (adverse) life-events (13 %), followed by practical 
barriers (11%).  A (perceived) lack of improvement/benefit, patient dissatisfaction with treatment 
and/or wish for different treatment, together accounted for 14% of dropout. Just over 4% of dropout 
was due to symptom improvement. 
 
3.7. Association of CBT task adherence with post-treatment OCD symptom reduction 
3.7.1. Face-to-face therapies  
Table 4 provides a descriptive summary of 7 studies (including one study reporting findings 
for therapist-delivered and self-help ERP combined (Tolin et al., 2007)) that tested the association 
between CBT task adherence and post-treatment OCD symptom severity. Studies used a range of task 
adherence measures and types of correlation (i.e. bivariate, partial and semi-partial), making it 
inadvisable to pool effect sizes (Aloe & Thompson, 2013). All 7 studies report a significant medium 
to large association of between-session CBT task adherence with post-treatment OCD symptom 
reduction.  
Three studies also considered the relationship between CBT task adherence and post-
treatment OCD symptom remission (Mataix-Cols et al., 2016). Simpson and colleagues (2011) 
showed that participants needed to achieve a mean total PEAS score of at least 5.6 (i.e. a minimum of 
75-90% good quality adherence to between-session ERP tasks as assigned and with minimal to no 
compulsions or safety aids) to achieve OCD symptom remission post-treatment. Wheaton, Galfalvy, 
et al. (2016) furthermore showed that when the three sub-scales of the PEAS were considered, i.e. a) 
quantity of exposure, b) quality of exposure, c) degree of success with response prevention or 
percentage resisted urges to ritualise, only item c was independently and positively associated with 










Abramowitz et al. (2002) also found that patients who achieved remission were significantly more 
adherent to between-session ERP task assignments and had a better understanding of the treatment 
rationale than those who did not. However, the authors used a Y-BOCS cut-off score of ≤ 16 to define 
remission rather than the recommended score of ≤12 (Mataix-Cols et al., 2016). Therefore, as some 
patients may not in fact have been in remission, these results need to be considered with caution. 
 
3.7.2. Remote therapies 
Six studies of remote therapies tested the relationship between the number of completed 
exposure tasks and post-treatment OCD symptom reduction, measured by the Y-BOCS. All studies 
involved the BT-STEPS programme, delivered via a web-based format (Diefenbach, Wootton, 
Bragdon, Moshier & Tolin, 2015; Kobak et al.,2015) or interactive voice response system (Bachofen 
et al., 1999; Greist et al., 1998, 2002; Kenwright et al., 2005). The BT-STEPS programme consists of 
9 steps; the first 3-4 involve self-assessment, the remainder self-treatment. Within the latter phase, 
ERP sessions can be completed as many times as needed.  
To meta-analyse the relationship between task adherence and post-treatment OCD symptom 
reduction, effect types other than correlations were converted into correlations using standard 
formulae (e.g. Borenstein et al., 2009). Diefenbach et al. (2015) was not included in the meta-analysis 
as it measured adherence differently, rating the highest step (out of 9) rather than the number of ERP 
tasks completed.  
There was a medium positive association between the number of ERP tasks/remote sessions 
completed and post-treatment OCD symptom reduction: r =.39 (95% CI [.23, .52], k=5, z= 4.66, 
p<.001; I²=31.9, Q(4) = 6.67, p =.16) (see Appendix G for forest plot). The correlation was reasonably 
stable (range: .34 - .43) when removing one study per pass. Heterogeneity of study estimates was 
small to moderate. 
 










There was no significant potential publication bias for the CBT refusal rate as Egger’s 
intercept test indicated the funnel plot asymmetry was not significant. For dropout, Egger’s intercept 
test shows significant funnel plot asymmetry (Intercept: -1.88, t=8.36, p <.001), indicating a potential 
publication bias towards excluding smaller studies with larger dropout rates. The trim-and-fill method 
showed that 52 study treatments should be trimmed to achieve an adjusted higher dropout rate of 
21.6% (95% CI [20.3, 23]). Too few studies contributed to the mean number and percentage of 
completed sessions or modules and to the association between remote ERP and post-treatment 
symptom reduction to consider publication bias (Borenstein et al., 2009, Sterne, Egger & Moher, 
2011). 
4. Discussion  
This meta-analysis found refusal and dropout rates of 15.6% and 15.9% respectively, 
suggesting that over 30% of eligible patients who are recommended CBT for OCD fail to initiate or 
complete treatment. Whilst a pooled refusal rate for CBT for OCD has not previously been reported, 
the dropout rate is consistent with two earlier meta-analyses of studies evaluating CBT for OCD (Öst 
et al, 2015; Swift & Greenberg, 2012). The risk of early dropout was 2.5 times greater than for late 
dropout. As early rather than late dropout appears to be related to poor outcomes (Aderka et al., 
2011), it suggests most patients who drop out from CBT for OCD are unlikely to have experienced 
clinically significant benefit. Indeed, the examination of reasons for dropout showed that dropout was 
rarely due to clinically significant symptom improvement.  This reinforces the need to better 
understand and address the risk of refusal and (early) dropout from CBT for OCD.  
This meta-analysis failed to find any significant moderators of refusal to inform our 
understanding of potential risk factors of refusal of CBT for OCD. Although refusal rates were not 
significantly higher for group than individual CBT, the exploration of reasons for refusal carefully 
suggests that a mismatch between patient preference and the treatment on offer, particularly when the 
treatment is group CBT, may affect patients’ opt-in to therapy. Feelings of unease or shame or 










participants anticipated insufficient individually tailored treatment within a group setting.  As dropout 
was significantly lower for group than individual therapy, it suggests that the group format may 
enhance adherence once participants commence therapy, e.g. being with other patients with OCD 
might help to normalise difficulties and support participants during challenging times in therapy. 
However, this finding could reflect a selection bias; e.g. group CBT participants may be more 
motivated or less (socially) anxious than participants in individual CBT. We would therefore urge 
caution in drawing the conclusion the group CBT is inherently more engaging than individual CBT.      
 The examination of patient reasons for nonadherence lends some support to the notion that 
negative perceptions of CBT and a lack of satisfaction or perceived benefit from therapy may 
contribute to treatment refusal and dropout (Mancebo et al., 2011). Interestingly, a sizeable portion of 
dropout was due to patients violating research eligibility criteria, e.g. changes in medication. This 
would typically not require withdrawal from CBT in routine clinical settings.   
 This review did not find a significant difference in dropout for different types of CBT (i.e. 
ERP, CBT, CT), which is consistent with other meta-analyses (Ong et al. 2016; Öst et al., 2015; Swift 
& Greenberg, 2014). Also, whilst one would assume that participants are more likely to stay 
motivated in therapy with increased therapist support, dropout from remote therapies was not 
significantly higher than for face-to-face therapies and therapist assistance in remote therapies did not 
moderate dropout from remote therapies. Therapist experience also did not affect dropout, which 
mirrors results from a meta-analysis of dropout from ERP (Ong et al., 2016). 
 Results suggest that, on average, participants who completed face-to-face CBT received a 
therapeutic ‘dose’ of therapy, commensurate with US and UK practice guidelines (APA, 2007; NICE, 
2005). However, results were highly heterogeneous and a significant number of treatment completers 
may not have received the recommended minimum 13 sessions; studies did not report the data needed 
to examine this further. Session/module completion for remote therapies appeared lower than for 
therapist-delivered therapies but, as most remote therapy studies reported figures for ITT rather than 










This review showed a consistent medium to large significant association between CBT task 
adherence and post-treatment OCD symptom reduction, in line with previous research into the 
association of homework with outcomes for CBT for a range of psychological disorders (e.g. 
Kazantzis et al., 2016). Most studies of CBT task adherence reported that adherence was at least 
satisfactory. However, as between-session task adherence likely needs to be high to achieve post-
treatment OCD symptom remission (e.g. Simpson et al., 2011), this may not necessarily be adequate 
(Mataix-Cols et al., 2016).  
 
4.1. Strengths and limitations   
To the best of our knowledge, this is the first comprehensive systematic review of the 
magnitude, moderators and reasons for poor adherence to CBT for OCD. It included a larger number 
of studies than previous meta-analyses of refusal and dropout (e.g. Ong et al., 2016; Öst et al., 2015; 
Swift & Greenberg, 2015) and considered both controlled and uncontrolled studies. This review 
adopted a wider focus on adherence by examining session attendance, module completion and 
between-session task adherence and reasons for non-adherence. By adopting a broad search strategy, 
it highlighted findings that were not necessarily foregrounded in study titles or abstracts. The large 
number of included studies allowed the examination of a range of moderators of refusal and dropout.  
Whilst a broad range of moderators were included, potentially important moderators may 
have been missed and some moderator analyses may have been under-powered. The quality of the 
included studies was not formally assessed. However, as quality assessment tools typically assess 
study features pertinent to a potential bias in effect sizes for therapy outcomes, they were not directly 
relevant to the current review (e.g. Jadad et al., 1996; Öst et al., 2008; Schulz, Altman & Moher, 
2010).  
 This review attempted to include studies reflective of real-life settings by including 
uncontrolled studies and examining the moderating effect of the sample’s clinical representativeness. 










treatment, additional supervision) (Hans & Hiller, 2013)) and only published papers were included. 
The current refusal and dropout rates might therefore not adequately reflect attrition in routine clinical 
settings. For example, Di Bona and colleagues (2014) found that 48% of respondents referred to 
Improving Access to Psychological Therapy (IAPT) services that routinely treat UK patients with 
common mental health difficulties including OCD, reported not attending the service. Richards and 
Borglin (2010) showed that, over a three-year period, 23% of IAPT patients dropped out of treatment. 
Attrition from CBT for OCD in routine settings may therefore be higher than the current rates suggest.  
 Many studies reported a two-step eligibility check; an initial (telephone) screening for 
eligibility, followed by face-to-face assessment to confirm the OCD diagnosis and severity of 
symptoms. Often a considerable number of patients met the inclusion criteria at telephone screening 
but disengaged prior to the confirmation of their eligibility following clinic-based assessment (when 
the refusal rate was calculated). This suggests that the current refusal rate is probably a conservative 
estimate. Reasons for refusal and dropout were based on a small subset of studies and may not 
adequately represent reasons for dropout for all studies included in the aggregation of refusal and 
dropout rates. 
The reported mean dropout rate was affected by a potential publication bias; the trim-and-fill 
test proposed an upwardly adjusted dropout rate (21.6%). Whilst small studies may have lower 
dropout rates associated with study design characteristics, the latter did not significantly moderate 
dropout. Alternatively, smaller studies were perhaps more often excluded due to ambiguous reporting 
on dropout. However, in that case, a small study absence would be observed at both the low and high 
end of study dropout. It is therefore possible that smaller studies with higher dropout rates are indeed 
less likely to be published.  
Studies spanned a period of more than 30 years, during which conceptual and 
technical aspects of ERP and CT have evolved (e.g. Jacoby & Abramowitz, 2016; Sookman, 










have been directly comparable and, together with the fact that there is considerable 
procedural overlap between these three treatment types (Abramowitz, Taylor, &McKay, 
2005), limits the conclusions that can be drawn from testing treatment type as a moderator of 
patient adherence.  
There were several limitations of the primary studies. Fifty percent of excluded full-text 
articles were discarded as they did not (clearly) report attrition data. Few of the 123 included studies 
reported on CBT task adherence. This is surprising, given the central importance attributed to 
participants practising therapy tasks between sessions for the success of CBT. The variability in the 
(quality of) measurement and reporting of CBT task adherence for face-to-face therapies made it 
impossible to pool study data.  
 
4.2. Clinical implications 
  Therapists should elicit and address any concerns and misconceptions patients have about 
CBT, and ERP in particular, at the earliest opportunity, i.e. during the patient’s initial assessment, 
perhaps with the aid of accounts from patients who have successfully completed therapy (using 
vignettes, audio or video material). Also, patients should ideally have a choice about their preferred 
treatment format.  
It would benefit patients to know that there is a significant relationship between task 
adherence and OCD symptom reduction and that recovery is more likely when task engagement is 
high. As is good clinical practice, therapists need to make sustained efforts (early on) to maximise 
patient engagement with key therapy tasks. It is also important to assess psychological factors such as 
patients’ degree of insight into their OCD symptoms and motivation for treatment (e.g. Bachofen et 
al., 1999; De Araujo et al., 1996; Tolin et al., 2004). Whilst Simpson, Zuckoff, et al. (2010) found that 
adding motivational interviewing to CBT did not enhance adherence, this was in a context of high 










showing poor motivation. Therapists should achieve a clear agreement with the patient on the tasks of 
therapy as Wheaton, Huppert et al. (2016) found that this predicted greater adherence to between-
session exposure tasks. As some studies show that task adherence predicted therapy outcomes early 
on in therapy (Simpson et al., 2011; De Araujo, Ito & Marks, 1996), any difficulties and 
misconceptions about between-session therapy tasks should be addressed at the earliest opportunity 
and clinicians should consider offering additional support, e.g. offering between-session phone-calls, 
increasing session frequency and/or including home visits, at this stage. Within the context of remote 
therapies, it would be advisable to build in (more) therapist assistance when patients first commence 
self-exposure, as this may enhance task adherence (e.g. Tolin et al., 2007). Wheaton, Galfalvy et al. 
(2016) show that the degree to which patients engage successfully in response prevention, rather than 
exposure per se, was predictive of post-treatment symptom reduction. Therefore, clinicians reviewing 
between-session ERP need to gain a clear understanding of patients’ degree and quality of response 
prevention during between-session ERP.  
 
4.3. Research implications 
We recommend that studies of CBT for OCD routinely report refusal and dropout rates and 
consistently distinguish patient- from clinician/researcher-initiated dropout, to aid research into 
predictors of patient-initiated dropout. Reasons for refusal and dropout should also be reported, aided 
by formal therapy adherence measures (e.g. Mancebo, Pinto, Rasmussen & Eisen, 2008). Qualitative, 
interview-based studies will enable a more in-depth understanding of reasons for non-adherence than 
a simple tally of refusal or dropout reasons. Enhanced within-study data on differences in 
sociodemographic and clinical characteristics between eligible patients, refusers, treatment completers 
and dropouts would enable pooling within-study data to inform our understanding of whether 
participant-level sociodemographic and clinical variables can predict non-adherence. More research is 
needed on whether psychological variables, such as participants’ beliefs about their mental health 










adherence (Santana & Fontenelle, 2011; Taylor, Abramowitz & McKay, 2012; Wierzbicki & Pekarik, 
1993). The relationships between the client-therapist relationship and patient adherence is also an area 
for further research  (Simpson et al., 2011; Wheaton, Huppert, Foa & Simpson, 2016).  An 
examination of group dynamics and peer relationships, in the context of group CBT, would also aid 
our understanding of whether and how peer support benefits patient adherence.  
The effect of different types of CBT (ERP, CT, CBT) on patient adherence requires further 
investigation, taking account of the conceptual and technical evolvement of these treatments over 
time. It would also be helpful to examine whether the way in which ERP tasks are completed, i.e. in a 
gradual, hierarchical manner (as informed by emotional processing theory (Foa & Kozak, 1986)) or a 
random, variable manner (as informed by inhibitory learning theory (Jacoby & Abramowitz, 2016)), 
affects patient dropout, sessions attendance and task adherence.   
The OCD research community should also aim to routinely report on task-adherence. It would 
benefit research in this area if researchers use the same measure of adherence to allow direct 
comparison between studies. We would recommend the PEAS (Simpson, Maher et al., 2010) as 
this is a measure of ERP task adherence that has already been used in multiple studies and it 
separately scores the degree of exposure and of response prevention and also captures the 
quality of exposure. This measure could be developed further, based on a shared understanding 
of the key features of well-designed exposure tasks that maximise exposure gains, e.g. informed by 
recent research on inhibitory learning theory (Craske, Treanor, Conway, Zbozinek & Vervliet 2014), 
and markers of successful adherence (e.g. Wheaton, Galfalvy, et al., 2016). Further research is 
needed to establish a suitable measure of adherence to other CBT tasks, e.g. cognitive 
restructuring, behavioural experiments, in the context of OCD. More objective measures of 
adherence, e.g. blind rating of video recordings of within- or between-session ERP, would enhance 
research in this area. Also, using apps to help patients record home practice might benefit self-report. 










measuring both over the course of treatment, it is not possible to firmly establish the direction of this 
relationship. Consistent application of agreed criteria for symptom remission (e.g. Farris, 
McLean, Van Meter, Simpson, & Foa, 2013) is also needed to advance our understanding of 
the role of patient adherence in symptom remission and longer-term recovery (Mataix-Cols et 
al., 2016). These are important areas of research to inform how best to achieve a high degree and 
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Descriptive summary of studies measuring mean CBT task adherence.  
Adherence Measure Study Treatment M (SD) Study authors’ 
description* 
PEAS (Simpson et al., 2010) 
 
7-point Likert scales: 
 
Item a) quantity of attempted 
exposure compared to quantity 
assigned (1= 0%, 7=100%) 
 
Item b) quality of exposures 
attempted (1= refused, 7=excellent) 
 
Item c) degree of ritual prevention 
(1= refused, 7=>90%) 
 



















Some to minimal 



































HCS (Primakoff et al., 1986) 
 
6-point Likert scale: 1 = did not 
attempt the assigned homework, 6 = 
attempted more than was requested. 




[4= The patient did a 
portion of the assigned 
homework, 5= the 





HCS (Primakoff et al., 1986) 
 
6-point Likert scale: 0 = did not 
attempt the assigned homework, 5 = 
attempted more than was requested. 
Whittal (2010) Once-weekly 
CT (N=37) 
3.50 (.95) ‘…did most of their 
assigned tasks each 
week’ (p.298) 
 
[3= The patient did a 
portion of the assigned 
homework, 4= the 
patient did the 
homework] 
CRES (Tolin et al., 2004) 
 
5-point Likert scale (0=made no effort 
to do ERP; 4=put their best effort into 
ERP) 
 
For remote ERP: therapist considered 
amount of book read, frequency and 
duration of exposure exercises and 
degree of effort to abstain from 
compulsive behaviours. 
Tolin (2004) Once-weekly 
ERP (N=15) 













1.50 (1.15) minimal to some effort 
Homework Compliance Rating 






















6-point Likert Scales: i) amount of 
effort put in (0=no effort, 5=best 
effort), ii) time spent on daily self-
exposure (0=none, 5=more than 2 
hours), iii) reading: amount of the 

























‘Some’ to ‘average’ 
effort 
2.88 (.95) time 
spent 
(participant) 






‘Average’ to ‘a lot’ 
7-point Likert Scale (0 = poor, 6 = 
outstanding) rating compliance with: 
i) patient understanding of treatment 
rationale (not reported here), ii) 
compliance with in-session exposure 
instruction (not reported here), iii) 
compliance with homework exposure 
instruction, iv) compliance with self-














Non-compliance = number of 
homework assignments (ERP) that 
were not completed. Based on patient 
logs. Completion = daily practice at 
least once a day and no compulsions 










Compliant. On average, 
participants did not 
complete almost 3 
assigned homework 
tasks. 
Number of home exposure exercises 
completed. 
(Minimum of 2 tasks after each 
session (sessions 3-11). Minimum 
total =18) 
 
Vogel (2004) Once-weekly 





At least 18 assignments 
were set and on average 
17 tasks were completed 
Once-weekly 




20.6 (7.2) At least 18 assignments 
were set and on average 
20 tasks were completed 





ERP + meds 
(N=16) 
70% Good compliance 
Once-weekly 
ERP + Pla 
(N=15) 
78% 
0-100% scale (0= ‘I did not try at all 
or I did not complete any of the 
exercises’, 100 =’ I gave the exercise 
a 100% effort and I completed 
exercise as discussed’) applied to 
both within- and between-session 
ERP 
Rowa (2007) Twice-weekly 
ERP in clinic 
(N=8-9) 
77% (average 





















Extent of participation on 0-100% 
scale 





67.9% (17.16) ‘participated relatively 
hard’ (participant-rated) 
Note: PEAS = Patient Exposure Adherence Scale, HCS = Homework Compliance Scale, CRES = Clinician 














Summary of reasons given for refusal (aggregated across studies) 
Categories (N, %) Reason N (%) 
Treatment type and 
format (23, 79.3) 
Did not want group treatment/preferred to wait for ind. therapy 12 (41.4) 
Rejected ERP 6 (20.7) 
Wanted face-to-face sessions 2 (6.9) 
Preferred group treatment 2 (6.9) 
Rejected computerized treatment programme 1 (3.4) 
Comorbidity  
(3, 10.3) 
Wanted/needed treatment for comorbid conditions 2 (6.9) 
Too anxious to participate (due to other anxiety problems) 1 (3.4) 
Practical barriers 
(3, 10.3) 
Too far/long to travel to clinic 1 (3.4) 
Moved out of area 1 (3.4) 
Sought treatment elsewhere 1 (3.4) 
Total  29 













Table 3: Summary of reasons given for dropout (aggregated across studies)  
Category (N, %) Reason N (%) 
Lack of engagement  
(60, 28.4) 
Did not wish to engage (further) in ERP 25 (11.8) 
Low/lack of motivation* 23 (10.9) 
Noncompliance** 7 (3.3) 
Too anxious about exposure 5 (2.4) 
Life events (27,12.8) Adverse life events (incl. medical illness) 16 (7.6) 
Moved out of area 7 (3.3) 
Pregnancy 4 (1.9) 
Practical barriers 
(24,11.4) 
Too little time to participate/work commitments 20(9.5) 
Too far/long to travel to clinic 3 (1.4) 
Technical problems (remote therapies) 1 (.5) 
No longer meets eligibility 
criteria (23,10.9) 
Stop/start medication  18 (8.5) 
alcohol misuse, change in diagnosis  5 (2.4) 
Deterioration in mental 
health (21,10) 
Deterioration in mental health/suicidality (requiring 
treatment) 
21 (10) 
Medication (18,8.5) Medication/placebo side effects 12 (5.7) 
Medication side-effects and/or noncompliance 6 (2.8) 
Lack of improvement   (16, 
7.6) 
Lack of improvement 7 (3.3) 
Patient reports treatment ineffective 5 (2.4)  
Limited benefit  4 (1.9) 
Dissatisfaction with 
treatment/wish for different 
treatment 
(13, 6.2) 
Wants more intensive treatment (than remote therapy) 3 (1.4) 
Wants to pursue psychopharmacological treatment 1 (.5) 
Treatment no longer corresponded to patient goals 2 (.9) 
Not willing to continue group therapy 1 (.5) 
No longer wants treatment 3 (1.4) 
Doesn’t feel ready to change 1 (.5) 
Treatment too emotionally burdensome 1 (.5) 
Dissatisfied with treatment 1(.5) 
Symptom improvement     
(9, 4.3) 
Treatment no longer required due to symptom 
improvement  
9 (4.3) 
Total  211 
Note: N=number of patients to which reason applied, %=percentage of patients (out of 211) to which reason 
applied 
* ERP (+/- medication/placebo)  












Table 4: Descriptive summary of studies of therapist-delivered therapies examining the association of 





Study TX Outcome measure N 
Type of 











28 (ITT) pr (a) -.61** 
Whittal et al. 
(2005) 





58 (C) pr (a) -.40** 
CRES 
 





15 (C) r .53* 














Simpson et al. 
(2011) 
Twice-weekly 
ERP + ERP-MI 

















Wheaton et al. 
(2016), using 














De Araujo et 
al. (1996) 






46 (C) r .33 
Note: Note. HCS = Homework Compliance Scale, CRES = Clinician Rated Effort Scale, PEAS = Patient 
Exposure Adherence Scale, Y-BOCS = Yale-Brown Obsessive-Compulsive Scale, ITT = intention to treat 
sample, C = completer sample, ES = effect size, a = controlled for baseline Y-BOCS /baseline Y-BOCS entered 
in step 1, pr = partial correlation, sr = semi-partial correlation. 
* p<.05,  












Records identified through other 
sources (n=8) 
Records after duplicates removed 
(n=4198) 
 
4198 records screened 
(n=4198) 




 Full-text articles assessed for 
eligibility  
(n=386) 




• Refusal: 26 (k=26) 
• Dropout 111 (k= 153) 
• Session attendance: 8 
(k=10) 
• Module completion: 8 
(k=10) 
• Association CBT task 
adherence remote ERP 
with post-treatment OCD 
symptom reduction: 5 
 
Descriptive synthesis:  
• CBT task adherence: 14  
• Reasons for refusal: 8  
• Reasons for dropout:41 
• Association face-to-face 
CBT task adherence 
therapies with post-
treatment OCD symptom 
reduction: 7 
  
Full-text articles excluded (N=263), with reasons:  
 
Study provides secondary analysis (overlap with 
previous trial) or follow-up data without adding 
new information/analysis about adherence (n= 87)   
 
No information provided on refusal, dropout or 
task adherence (n = 81)  
 
Not possible to distinguish study and treatment 
dropout or information on refusal, dropout or 
engagement is otherwise ambiguous (n = 53)  
 
Internationally recognised criteria are not applied 
(or reported) to diagnose OCD (n = 17)  
 
Inpatients (n =10) 
 
CBT is not provided as a stand-alone psychological 
treatment or engagement information is not 
provided for CBT (n = 8) 
 
No treatment information (e.g. length, intensity, 
number of sessions) (n = 3)  
 
Pharmacological treatment only (n = 2) 
 
Outside of age range (n= 1) 
 
Language (n= 1) 
 
Fig. 1: Study flow 
Records identified through 
database searching (n=7717) 
 
 
